A Clinical Research Study for Dyskinesia Due to Cerebral Palsy (DCP)

What opportunities could be created through cerebral palsy research?

If you or someone you care for is living with cerebral palsy and involuntary movements that are difficult to control (dyskinesia), consider the Kinect-DCP Study.

See who may qualify

About the Kinect-DCP Study

The Kinect-DCP Study is currently enrolling children, adolescents, and adults 6 to 70 years of age who have been diagnosed with dyskinesia due to cerebral palsy (DCP). This clinical research study is testing a study drug, called valbenazine, to determine if it is safe to use and if it helps to improve involuntary movements for individuals with DCP. Compensation for time and travel may be available.

To see if you or someone you care for may qualify, please answer the few questions below.

Learn more about the Kinect-DCP Study.

See Who May Qualify

This website uses Secure Socket Layer technology and encryption methods to protect personal health information. If you’d like to know more about our privacy policy, click here.

Step 1 of 3

By answering the following questions, you agree to have the information you provide kept for the duration of the study. You will only be contacted by phone or email (as provided) regarding interest in study participation. If you are completing the prescreener on behalf of the person you care for, please answer questions using their information.

Do you agree to submit this information?
Is the person interested in the Kinect-DCP Study yourself or the person you care for?